[1] Petersen RC.Mild cognitive impairment as a diagnostic entity[J].J Intern Med,2004,256(3):183-194.
[2] Petersen RC,Doody R,Kurz A,et al.Current concepts in mild cognitive imparment[J].Arch Neurol,2001,58(12):1985-1992.
[3] Johnson KA,Moran EK Becker JA.et al.Single photon emission computed tomography perfusion differences in mild cognitive impairment[J].J Neural Neurosurg Psychiatry,2007,78(3):240-247.
[4] Hirao K Ohnishi T, Hirata Y,et al.The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT[J].Neuroimage,2005, 28(4):1014-1021.
[5] Ishiwata A,Sakayori O,Mineshima S.et al.Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment:a qualitative and quantitative SPECT study[J].Acta Neurol Scand,2006,114(2):91-96.
[6] 高平,秦绍森,蔡晓杰,等.Alzheimer病与轻度认知功能障碍的脑SPECT显像[J].中华核医学杂志,2006,26(4):213-215.
[7] Chételat G,Desgranges B,de la Sayette V,et al.Mild cognitive impairment:Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?[J].Neurology,2003,60(8):1374-1377.
[8] Pardo JV,Lee JT,Sheikh SA.et al.Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal agindfl.Neuroimage,2007,35(3):1231-1237.
[9] Mosconi L,De Santi S,Li J,et al.Hippocampal hypometabotism predicts cognitive decline from normal aging[J].Neurobiol Aging, 2008,29(5):676-692.
[10] Kropholler MA,Boellaard R,van Berckel BN,et al.Evaluation of reference regions for (R)-[(11)C] PKlll95 studies in Alzheimer's disease and mild cognitive impairment[J].J Cereb Blood Flow Metab,2007,27(12):1965-1974.
[11] Hasselbalch SG,Madsen K,Svarer C.et al.Reduced 5-HT2A.receptor binding in patients with mild cognitive impairment[J]. Neurobiol Aging,2008,29(12):1830-1838.
[12] Huang C,Eidelberg D,Habeck C,et al.Imaging markers of mild cognitive impairment:multivariate analysis of CBF SPECT[J]. Neurobiol Aging,2007,28(7):1062-1069.
[13] Borroni B,Anchisi D,Paghera B.et al.Combined 90Tc-ECD SPECT and neurepsychological studies in MCI fur the assessment of conversion to AD[J].Neurobiol Aging,2006,27(1):24-31.
[14] 王荫华,陈晓红,汤哲,等.轻度认知功能障碍的神经心理学研究和ApoE基因多态性分析[J].中国康复理论与实践,2005,11(3):202-205.
[15] Mosconi L Herholz k Prohovnik I,et al.Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve[J].J Neurol Neurosurg Psychiatry. 2005,76(1):15-23.
[16] Drzezga A,Grimmer T,Riemenschneider M,et al.Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET[J].J Nucl Med,2005,46(10):1625-1632.
[17] Mosconi L.Perani,D,Sorbi S,et al.MCl conversion to dementia and the APOE genotype:a prediction study with FDG-PET[J].Neurology,2004,63(12):2332-2340.
[18] Forsberg A,Engler H,Almkvist O,et al.PET imaging of amyloid deposition in pafients with mild cognitive impairment[J].Neurobiol Aging,2008.29(10):1456-1465.
[19] Fellgiebel A,Scheufieh A,Bartenstein P,et al.FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment[J].Psychiatry Res,2007,155(2):167-171.